Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-02

FDA Approved: NALOXONE HYDROCHLORIDE — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approved a supplemental application for Naloxone Hydrochloride from Eugia US LLC under ANDA 213279, granting approval of the generic product. This action up…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

SUPPL AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)